Rahul Rishi, DO
Allergy & Immunology · Phoenix, AZNPI 1316258379
Payments from drug & device makers
Across 584 payments — averaging $46.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$15K
- AstraZeneca$3K
- GSK$2K
- CSL Behring$1K
- Sanofi$985
- Regeneron Healthcare Solutions, Inc.$918
- plus $5K from 30 others
What the payments were for
- Consulting fees$11,42542%
- Travel & lodging$1,2054%
- Food & beverage$14,63853%
- Education$1431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 46 | $14,575 |
| AstraZeneca | 80 | $2,982 |
| GSK | 97 | $1,690 |
| CSL Behring | 56 | $1,429 |
| Sanofi | 44 | $985 |
| Regeneron Healthcare Solutions, Inc. | 35 | $918 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $755 |
| Genentech USA, Inc. | 34 | $665 |
| Biocryst US Sales Co., LLC | 22 | $481 |
| Grifols USA, LLC | 16 | $370 |
| Pfizer | 25 | $337 |
| Incyte Corporation | 12 | $291 |
| Kaleo, Inc. | 10 | $256 |
| Blueprint Medicines Corporation | 9 | $224 |
| Cycle Pharmaceuticals Inc | 4 | $194 |
| Amgen | 9 | $157 |
| Organon | 2 | $128 |
| Pharming Healthcare, Inc. | 7 | $119 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $104 |
| Optinose US, Inc. | 5 | $100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $81 |
| Sanofi-aventis U.S. LLC | 2 | $78 |
| Boehringer Ingelheim | 4 | $73 |
| Ionis Pharmaceuticals, Inc. | 3 | $55 |
| LEO Pharma Inc. | 2 | $52 |
| AbbVie | 2 | $50 |
| Aimmune Therapeutics, Inc. | 3 | $46 |
| Covis Pharma GmbH | 2 | $44 |
| Galderma Laboratories, L.p. | 1 | $29 |
| Merck | 1 | $27 |
| Sanofi US Services Inc. | 1 | $26 |
| Biocryst Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $20 |
| Philips North America LLC | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,411 in reported general payments places this provider in the 80th percentile of 90 allergy & immunology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Advair HfaFluticasone Propion/Salmeterol | 17 | $10,674 |
| Ipratropium Bromide | 67 | $2,195 |
| Azelastine Hcl | 22 | $621 |
| Famotidine | 26 | $566 |
| Montelukast Sodium | 48 | $366 |
| Clarithromycin | 17 | $344 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Phoenix
- Keith SaccoPhoenix$366K
- Cindy BauerPhoenix$265K
- Reimus ValenciaPhoenix$49K
- Mark SchubertPhoenix$3K
- Bartlomiej LeykoPhoenix$2K
- Ifat KrasePhoenix$1K
- Jonathon ScheningPhoenix$1K
- Brenna LaberePhoenix$1K
- Catherine FreemanPhoenix$985
- Connie HsuLitchfield Park$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.